Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

Fig. 2

Kaplan-Meier curves showing the association between biomarkers and one-year PFS. A IO score stratified by the prospectively set ≥0.09 positivity threshold for 67 NSCLC patients; B PD-L1 TPS stratified by the 1% positivity threshold for 59 NSCLC patients; C TMB stratified by the ≥10 mut/MB threshold for 36 NSCLC patients. A-C significance values calculated by log-rank test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us